Direktorat Registrasi ObatValid

MEFLOSIN

BPOM Number: DKL9516106909A1
Approved: 7 August 2025
Expiry: 16 April 2030
Form: KAPLET SALUT SELAPUT

About This Registration

MEFLOSIN is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKL9516106909A1. Its registration status based on the recorded expiry date is Valid, with the licence valid until 16 April 2030. The product is registered to METISKA FARMA - INDONESIA. BPOM first approved this registration in August 2025. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application: newaero
Packaging: DUS, 3 STRIP @ 10 KAPLET SALUT SELAPUT
Department: Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

METISKA FARMA - INDONESIA
KODYA JAKARTA SELATAN
NPWP: 010008910062000
owner
View profile →

Manufacturing Sites

METISKA FARMA - INDONESIA
KODYA JAKARTA SELATAN
primary
View profile →

Ingredients (1)

CIPROFLOXACIN HYDROCHLORIDE MONOHYDRATE

Market Intelligence

Owner Portfolio: METISKA FARMA - INDONESIA holds 34 BPOM registrations
Manufacturer Scale: METISKA FARMA - INDONESIA produces 34 registered products
Registration Age: Registered for 1 year, 2 months